Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 3-year average of -76.70%, near the high end of its 3-year range (-1437.75%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-76.70%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Tvardi Therapeutics, Inc.
Market Cap
$10.13M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-76.70%
5Y Avg
N/A
Market Cap
$10.06M
Net Profit Margin
-90116.36%
TTM Avg
-139631.82%
3Y Avg
-71156.88%
5Y Avg
-48680.54%
Market Cap
$10.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.21M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
Market Cap
$9.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-312.43%
5Y Avg
-391.43%
Market Cap
$9.83M
Net Profit Margin
-71.51%
TTM Avg
-193.27%
3Y Avg
-1708.98%
5Y Avg
-2188.03%
Market Cap
$10.45M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.71M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | $10.13M | 0.00% | 0.00% | -76.70% | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | -90116.36% | -139631.82% | -71156.88% | -48680.54% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -141.28% | -101.58% | -179.50% | -204.48% |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | 0.00% | 0.00% | -312.43% | -391.43% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -71.51% | -193.27% | -1708.98% | -2188.03% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| MetaVia Inc. (MTVA)vs › | $9.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pluri Inc. (PLUR)vs › | $10.68M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -190.97% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -1437.75% |
| 2023-12-31 | -1076.46% |
| 2023-09-30 | -576.08% |
